These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 15342416
1. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Al-Madhoun AS, Johnsamuel J, Barth RF, Tjarks W, Eriksson S. Cancer Res; 2004 Sep 01; 64(17):6280-6. PubMed ID: 15342416 [Abstract] [Full Text] [Related]
2. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S. Cancer Res; 2004 Sep 01; 64(17):6287-95. PubMed ID: 15342417 [Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. J Med Chem; 2005 Feb 24; 48(4):1188-98. PubMed ID: 15715485 [Abstract] [Full Text] [Related]
4. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. Appl Radiat Isot; 2004 Nov 24; 61(5):1125-30. PubMed ID: 15308203 [Abstract] [Full Text] [Related]
5. Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. Lunato AJ, Wang J, Woollard JE, Anisuzzaman AK, Ji W, Rong FG, Ikeda S, Soloway AH, Eriksson S, Ives DH, Blue TE, Tjarks W. J Med Chem; 1999 Aug 26; 42(17):3378-89. PubMed ID: 10464024 [Abstract] [Full Text] [Related]
13. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates. Leśnikowski ZJ, Paradowska E, Olejniczak AB, Studzińska M, Seekamp P, Schüssler U, Gabel D, Schinazi RF, Plesek J. Bioorg Med Chem; 2005 Jul 01; 13(13):4168-75. PubMed ID: 15878666 [Abstract] [Full Text] [Related]
15. Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog. Schmid M, Neumaier B, Vogg AT, Wczasek K, Friesen C, Mottaghy FM, Buck AK, Reske SN. Nucl Med Biol; 2006 Apr 01; 33(3):359-66. PubMed ID: 16631084 [Abstract] [Full Text] [Related]
16. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues. Yan J, Naeslund C, Al-Madhoun AS, Wang J, Ji W, Cosquer GY, Johnsamuel J, Sjöberg S, Eriksson S, Tjarks W. Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2209-12. PubMed ID: 12127539 [Abstract] [Full Text] [Related]
17. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA. Mol Pharm; 2005 Aug 19; 2(2):151-6. PubMed ID: 15804189 [Abstract] [Full Text] [Related]
19. 5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts. Wang L, Eriksson S. Nucleosides Nucleotides Nucleic Acids; 2008 Jun 19; 27(6):858-62. PubMed ID: 18600552 [Abstract] [Full Text] [Related]